Opatanol (Olopatadine)

Olopatadine, the active ingredient in Opatanol, is a H1‑receptor antagonist presented as an ophthalmic solution for ocular use. It alleviates symptoms of allergic eye conditions such as itching, redness, and swelling in patients with seasonal or perennial allergies.

GNH USA supplies Opatanol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution. Clients benefit from consistent product availability, regulatory support, and responsive technical assistance throughout the supply chain.

Opatanol, an ophthalmic antihistamine, is indicated for allergic eye disorders that involve histamine‑mediated inflammation. - Allergic conjunctivitis: reduces ocular itching, redness, and swelling caused by allergen exposure. - Seasonal allergic conjunctivitis: provides relief of eye symptoms during pollen or mold seasons. - Ocular itching due to allergy: alleviates persistent itch and discomfort associated with environmental allergens. - Contact lens‑related allergic irritation: helps minimize discomfort in lens wearers with allergic responses.

The most frequently reported ocular and systemic reactions to Opatanol are listed below.

Common Side Effects: - Eye irritation or burning sensation: mild discomfort that usually resolves quickly. - Blurred vision: temporary reduction in visual clarity after dosing. - Dry eye sensation: feeling of dryness or sand‑like texture. - Headache: mild headache occurring shortly after use. - Transient taste disturbance: brief metallic or bitter taste after drops. - Mild redness: slight conjunctival redness not requiring treatment.

Serious or Rare Side Effects: - Anaphylactic or severe allergic reaction: rapid onset of swelling, hives, or breathing difficulty. - Corneal ulcer or keratitis: ulceration or inflammation of the cornea requiring urgent care. - Significant increase in intra‑ocular pressure: rise in eye pressure that may threaten optic nerve health. - Severe eye inflammation (uveitis): painful redness and photophobia needing specialist evaluation. - Vision loss or persistent visual disturbances: sudden loss of vision or ongoing visual anomalies. - Severe headache with neurological signs: intense headache accompanied by dizziness or visual changes.

When using Opatanol, consider the following precautions to ensure safe and effective therapy. - Allergy assessment: avoid use if the patient has known hypersensitivity to olopatadine or any excipients. - Contact lens use: discontinue wearing contact lenses for at least 15 minutes after instillation. - Pregnancy and lactation: consult a healthcare professional before use during pregnancy or breastfeeding. - Ocular irritation: stop treatment and seek medical advice if severe eye irritation or worsening symptoms occur. - Store at room temperature: keep the bottle in the original packaging, protect from light and moisture, and store below 25 °C.

Opatanol may interact with other ophthalmic or systemic agents; the following interactions are recognized.

Major Interactions (Avoid): - Concurrent use of other ocular antihistamines: may increase risk of local irritation. - Preservative‑containing contact lens solutions: can exacerbate ocular discomfort. - Systemic MAO inhibitors: potential for enhanced systemic antihistaminic effects.

Moderate Interactions (Monitor Closely): - Topical corticosteroids: monitor for additive ocular pressure changes. - Non‑steroidal anti‑inflammatory eye drops: observe for increased irritation. - Systemic antihistamines or decongestants: watch for additive sedation or dryness.